Recursion Pharmaceuticals (NASDAQ:RXRX) stock is one of those lesser-known mid-cap biotech plays that investors may be ...

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to ...

Apple Holic Appleholic, (noun), æp·əl-hɑl·ɪk: An imaginative person who thinks about what Apple is doing, why and where it is going. Delivering popular Apple-related news, advice and ...